Saturday, October 24, 2026 · Washington, D.C. Live
Breaking
Advertisement
Politics5:00 AM ET

Personalized Cancer Vaccine Shows Promise In Major Trial

Pharmaceutical companies Merck and Moderna reported that an experimental personalized mRNA vaccine, given alongside the immunotherapy drug Keytruda, reduced the risk of melanoma recurrence or death by 42% compared with Keytruda alone. The P

Republican Ledger staff · 5:00 AM ET

Personalized Cancer Vaccine Shows Promise In Major Trial
The Republican Ledger

Our newsroom is writing this report…

Pharmaceutical companies Merck and Moderna reported that an experimental personalized mRNA vaccine, given alongside the immunotherapy drug Keytruda, reduced the risk of melanoma recurrence or death by 42% compared with Keytruda alone. The Phase 3 trial included 1,137 patients with Stage IIB-IV melanoma whose tumors had been surgically removed.

The findings could bring the drugmakers ...

The Morning Ledger

Conservative news, first thing, every morning.

Politics, the economy, and the day's front page — free in your inbox.

Recommended Stories

Trending now

Reader Discussion

0 comments

Reviewed by an editor before it appears · 2000 characters left

  • Loading comments…
Sponsored